Subscribe By E-Mail

Chinese drug maker Aosaikang dashes IPO hopes

Hopes for an initial public offering bonanza on the mainland were dashed yesterday after drug maker Jiangsu Aosaikang Pharmaceutical halted its fundraising process because of concerns it was too big.


Markets & Investing feed